Free Trial

Quipt Home Medical (QIPT) Competitors

Quipt Home Medical logo
$2.06 +0.06 (+2.75%)
As of 01:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

QIPT vs. VMD, TOI, DCGO, XGN, EUDA, SERA, NAKA, KDLY, ATPC, and CORBF

Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Viemed Healthcare (VMD), Oncology Institute (TOI), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry.

Quipt Home Medical vs. Its Competitors

Quipt Home Medical (NASDAQ:QIPT) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Viemed Healthcare has a net margin of 5.28% compared to Quipt Home Medical's net margin of -3.66%. Viemed Healthcare's return on equity of 9.49% beat Quipt Home Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Quipt Home Medical-3.66% -8.38% -3.63%
Viemed Healthcare 5.28%9.49%7.14%

42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 13.4% of Quipt Home Medical shares are held by insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Quipt Home Medical had 5 more articles in the media than Viemed Healthcare. MarketBeat recorded 6 mentions for Quipt Home Medical and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.93 beat Quipt Home Medical's score of 0.79 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Quipt Home Medical Positive
Viemed Healthcare Positive

Quipt Home Medical currently has a consensus price target of $2.85, suggesting a potential upside of 38.69%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Quipt Home Medical is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quipt Home Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Viemed Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Viemed Healthcare has lower revenue, but higher earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quipt Home Medical$245.91M0.36-$6.76M-$0.21-9.79
Viemed Healthcare$224.26M1.17$11.27M$0.3022.18

Quipt Home Medical has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500.

Summary

Viemed Healthcare beats Quipt Home Medical on 11 of the 16 factors compared between the two stocks.

Get Quipt Home Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QIPT vs. The Competition

MetricQuipt Home MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$89.27M$10.19B$5.56B$9.30B
Dividend YieldN/A2.09%4.23%4.03%
P/E Ratio-9.7916.9728.6119.64
Price / Sales0.3628.48437.49188.30
Price / Cash1.8722.6736.0257.93
Price / Book0.833.608.185.63
Net Income-$6.76M$233.40M$3.23B$257.73M
7 Day Performance9.31%-2.88%-0.25%0.07%
1 Month Performance3.27%1.60%5.40%8.32%
1 Year Performance-40.26%-19.42%26.35%13.78%

Quipt Home Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QIPT
Quipt Home Medical
3.1569 of 5 stars
$2.06
+2.8%
$2.85
+38.7%
-35.3%$89.27M$245.91M-9.791,200
VMD
Viemed Healthcare
1.2262 of 5 stars
$6.87
-3.9%
N/A-3.1%$282.60M$224.26M22.901,179
TOI
Oncology Institute
1.8609 of 5 stars
$2.56
+1.6%
$7.00
+173.4%
+494.0%$224.87M$403.15M-3.66660Analyst Forecast
Gap Up
DCGO
DocGo
2.1835 of 5 stars
$1.52
-3.8%
$3.56
+134.2%
-55.3%$161.13M$520.50M-76.004,407
XGN
Exagen
3.8922 of 5 stars
$6.96
-1.3%
$7.50
+7.8%
+242.4%$150.16M$55.64M-8.29220News Coverage
EUDA
EUDA Health
1.2558 of 5 stars
$3.33
-1.5%
N/A-15.4%$125.59M$4.01M0.002
SERA
Sera Prognostics
0.3957 of 5 stars
$2.42
-2.8%
N/A-61.6%$93.81M$80K-2.57120
NAKA
KindlyMD
N/A$12.04
-5.6%
N/AN/A$76.88M$2.72M-15.64N/A
KDLY
Kindly MD
N/A$12.75
-2.8%
N/A+414.5%$76.78M$2.47M-16.56N/A
ATPC
Agape ATP
0.545 of 5 stars
$1.40
+2.6%
N/A-65.6%$68.01M$1.29M-2.3240Gap Down
CORBF
Global Cord Blood
N/A$0.55
-62.1%
N/AN/A$66.85M$196.12M0.001,200Gap Down

Related Companies and Tools


This page (NASDAQ:QIPT) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners